| OAA0202 | SMAC mimetic plus triple combination bispecific HIVxCD3 DART® molecules in SHIV.CH505-infected, ART-suppressed rhesus macaques | Oral abstract session with live Q&A | A18 |
| OAXLB0105 | The first long-term remission of chronic HIV-1 infection without myeloablation? | Oral abstract session with live Q&A | A18 |
| PEA0061 | Identification of novel compounds that reactivate HIV replication from latently infected CD4 T cells | E-poster | A18 |
| LBPEA06 | Reanalysis of native RNA sequencing of HIV-1 supports spliced HIV mRNA packaging into virions as a new hybrid segmented retrovirus model | E-poster | A2 |
| PEA0010 | HIV genetic variability and isomiR presence: Effect on the effectiveness of anti-HIV microRNAs | E-poster | A2 |
| PEA0011 | Insights from HIV-1 transgene insertions in the murine model of HIV-associated nephropathy | E-poster | A2 |
| PEA0012 | Autophagy flux modulating compounds influence human immunodeficiency virus type 1 infection | E-poster | A2 |
| PEA0013 | Expression of CircRNAs in HIV-1 infection | E-poster | A2 |
| OAA0205 | Combining a conditional suicide gene with CCR5 knockout for anti-HIV gene therapy | Oral abstract session with live Q&A | A20 |
| OAA0206 | Gene therapy with an anti-tat gene can strongly block HIV-1 transcription and virus replication in mouse models of infection | Oral abstract session with live Q&A | A20 |